E-LIB Suche - Ergebnisse für: You, Maojin

1

Cost-effectiveness analysis of zolbetuximab plus mFOLFOX6 a..:

Huang, Yufan ; You, Maojin ; Wu, Qundan.
Frontiers in Pharmacology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

2

Cost-effectiveness analysis of transarterial chemoembolizat..:

He, Ying ; Lin, Wangchun ; Cai, Zhongjie...
Frontiers in Pharmacology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

3

Cost-effectiveness analysis of dostarlimab plus carboplatin..:

You, Maojin ; Zeng, Xiaoling ; Zhang, Jinrong...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

4

Cost-effectiveness analysis of adebrelimab combined with ch..:

You, Maojin ; Chen, Ruijia ; Wu, Qingfeng...
Frontiers in Pharmacology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

5

Cost-effectiveness analysis of sintilimab plus chemotherapy..:

You, Maojin ; Huang, Yufan ; Cai, Zhongjie...
Frontiers in Oncology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

6

Cost-Effectiveness Analysis of Capecitabine Plus Oxaliplati..:

Chen, Ruijia ; Zhang, Yalan ; Lin, Kongying...
Frontiers in Pharmacology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

7

Cost-effectiveness analysis of dostarlimab plus carboplatin..:

You, Maojin ; Zeng, Xiaoling ; Zhang, Jinrong...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507332/. , 2023

Link: http://www.ncbi.nlm.nih...

8

Cost-effectiveness analysis of transarterial chemoembolizat..:

He, Ying ; Lin, Wangchun ; Cai, Zhongjie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512705/. , 2023

Link: http://www.ncbi.nlm.nih...

9

Cost-effectiveness analysis of zolbetuximab plus mFOLFOX6 a..:

Huang, Yufan ; You, Maojin ; Wu, Qundan.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500349/. , 2023

Link: http://www.ncbi.nlm.nih...

10

Cost-effectiveness analysis of sintilimab plus chemotherapy..:

You, Maojin ; Huang, Yufan ; Cai, Zhongjie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773135/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Cost-effectiveness analysis of adebrelimab combined with ch..:

You, Maojin ; Chen, Ruijia ; Wu, Qingfeng...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643856/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Table1_Cost-effectiveness analysis of transarterial chemoem..:

Ying He ; Wangchun Lin ; Zhongjie Cai...
doi:10.3389/fphar.2023.1219694.s001. , 2023

Link: https://doi.org/10.3389/..

13

Table1_Cost-effectiveness analysis of zolbetuximab plus mFO..:

Yufan Huang ; Maojin You ; Qundan Wu.
doi:10.3389/fphar.2023.1238009.s001. , 2023

Link: https://doi.org/10.3389/..

14

Cost-effectiveness analysis of zolbetuximab plus mFOLFOX6 a..:

Yufan Huang ; Maojin You ; Qundan Wu.
https://www.frontiersin.org/articles/10.3389/fphar.2023.1238009/full. , 2023

Link: https://doi.org/10.3389/..

15

Cost-effectiveness analysis of transarterial chemoembolizat..:

Ying He ; Wangchun Lin ; Zhongjie Cai...
https://www.frontiersin.org/articles/10.3389/fphar.2023.1219694/full. , 2023

Link: https://doi.org/10.3389/..